Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 2 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 12 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
IMMORAD from Gent, company number BE0793209184, closed financial year 2025 with a result of € 25,434 after tax. For that financial year IMMORAD recorded a gross margin of € 96,544 and equity of € -63,531. Compared with financial year 2024, the result moved from € -90,965 to € 25,434. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on January 30, 2026.
€ -63,531
▲ € 25,434 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 25,434
▲ still € 90,966 loss in 2024
Profit after tax over the fiscal year.
€ 14,543
▼ 53% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -65,531.
People and assets in 2025
€ 74,276
▼ 5% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1 million
▼ 5% vs 2024
€ 54,866 is repaid this year. At this pace the long-term loan is gone in ≈ 19 years.
€ 768
▲ € 636 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 5,482
▼ 4% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 10,513 | € 96,544 | ▲ € 86,031 |
| Profit after taxes | € -90,965 | € 25,434 | ▲ € 116,400 |
| Equity | € -88,965 | € -63,531 | ▲ € 25,434 |
| Total debts | € 1,163,567 | € 1,090,893 | ▼ 6% |
| Cash | € 30,761 | € 14,543 | ▼ 53% |
| Land & buildings | € 880,957 | € 859,895 | ▼ 2% |
| Retained profit | € -90,965 | € -65,531 | ▲ € 25,434 |
| Bank debt | € 1,074,863 | € 1,023,046 | ▼ 5% |
| Balance sheet total | € 1,074,602 | € 1,027,361 | ▼ 4% |
Key figures of IMMORAD, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to IMMORAD?
What happened at IMMORAD in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 25,434. Source: NBB ↗
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 90,966 loss in 2024 to € 25,434 profit in 2025.
Paid € 0 in corporate taxes since 2024.
Best year ever: 2025, with € 25,434 profit.
Management
Behind IMMORAD are Thomas Backaert and Niels Favoreel. The same people are also behind RX Mariakerke. Thomas Backaert is also behind OCURAD and ARTSEN RADIOLOGIE AZ DELTA. Niels Favoreel is also behind IATREION, Radiologie Dr. Favoreel and RX FAVOREEL.
Directors
According to the 2025 annual accounts
Niels Favoreel
Director
Also active at: IATREION, Radiologie Dr. Favoreel, RX FAVOREEL, RX Mariakerke
Establishments
Establishment units
Physical locations of this company
Brugsesteenweg 605
9030 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0793.209.184
- VAT number
- BE 0793.209.184
- Registered office
- Brugsesteenweg 605, 9030 Gent
- Names & denominations
- IMMORAD
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 2 November 2022
- Peppol
- Active · Active since 21 Oct 2026
- Activities · NACE
Handel in eigen onroerend goed